Cognizance Market Research

Global Myasthenia Gravis Market to Reach US$2.89 Billion by 2030, Driven by Immunotherapies and Biologic Advancements

Myasthenia gravis (MG) is a chronic, progressive, and uncommon neuromuscular disorder. In this autoimmune disorder in which the head, limb, spinal, ocular, and respiratory muscles …

Read More

Cognizance Market Research

Global Acute Repetitive Seizures Market Advances with Innovative Rescue Therapies and Growing Epilepsy Awareness

Global acute repetitive seizures also called seizure clusters, are common phenomena in patients with epilepsy. Epilepsy is the most common neurological disease with 70 million …

Read More